Global Venous Thromboembolism Therapeutics Market Size, Status, Research and Forecast 2019-2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 347732

In 2018, the global Venous Thromboembolism Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Venous Thromboembolism Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Venous Thromboembolism Therapeutics development in United States, Europe and China.

The key players covered in this study
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo
Bristol-Myers Squibb (BMS)
Bayer HealthCare
Pfizer
Leo Pharma
Portola Pharmaceuticals
ThromboGenics
Ionis Pharmaceuticals
GlycoMimetics
BioInvent International

Market segment by Type, the product can be split into
Factor Xa Inhibitors
Direct Thrombin Inhibitors
Heparin
Vitamin K Antagonists
Other

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Venous Thromboembolism Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Venous Thromboembolism Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Venous Thromboembolism Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Factor Xa Inhibitors
1.4.3 Direct Thrombin Inhibitors
1.4.4 Heparin
1.4.5 Vitamin K Antagonists
1.4.6 Other
1.5 Market by Application
1.5.1 Global Venous Thromboembolism Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Venous Thromboembolism Therapeutics Market Size
2.2 Venous Thromboembolism Therapeutics Growth Trends by Regions
2.2.1 Venous Thromboembolism Therapeutics Market Size by Regions (2014-2025)
2.2.2 Venous Thromboembolism Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Venous Thromboembolism Therapeutics Market Size by Manufacturers
3.1.1 Global Venous Thromboembolism Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Venous Thromboembolism Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Venous Thromboembolism Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Venous Thromboembolism Therapeutics Key Players Head office and Area Served
3.3 Key Players Venous Thromboembolism Therapeutics Product/Solution/Service
3.4 Date of Enter into Venous Thromboembolism Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Venous Thromboembolism Therapeutics Market Size by Type (2014-2019)
4.2 Global Venous Thromboembolism Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Venous Thromboembolism Therapeutics Market Size (2014-2019)
5.2 Venous Thromboembolism Therapeutics Key Players in United States
5.3 United States Venous Thromboembolism Therapeutics Market Size by Type
5.4 United States Venous Thromboembolism Therapeutics Market Size by Application

6 Europe
6.1 Europe Venous Thromboembolism Therapeutics Market Size (2014-2019)
6.2 Venous Thromboembolism Therapeutics Key Players in Europe
6.3 Europe Venous Thromboembolism Therapeutics Market Size by Type
6.4 Europe Venous Thromboembolism Therapeutics Market Size by Application

7 China
7.1 China Venous Thromboembolism Therapeutics Market Size (2014-2019)
7.2 Venous Thromboembolism Therapeutics Key Players in China
7.3 China Venous Thromboembolism Therapeutics Market Size by Type
7.4 China Venous Thromboembolism Therapeutics Market Size by Application

8 Japan
8.1 Japan Venous Thromboembolism Therapeutics Market Size (2014-2019)
8.2 Venous Thromboembolism Therapeutics Key Players in Japan
8.3 Japan Venous Thromboembolism Therapeutics Market Size by Type
8.4 Japan Venous Thromboembolism Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Venous Thromboembolism Therapeutics Market Size (2014-2019)
9.2 Venous Thromboembolism Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Venous Thromboembolism Therapeutics Market Size by Type
9.4 Southeast Asia Venous Thromboembolism Therapeutics Market Size by Application

10 India
10.1 India Venous Thromboembolism Therapeutics Market Size (2014-2019)
10.2 Venous Thromboembolism Therapeutics Key Players in India
10.3 India Venous Thromboembolism Therapeutics Market Size by Type
10.4 India Venous Thromboembolism Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Venous Thromboembolism Therapeutics Market Size (2014-2019)
11.2 Venous Thromboembolism Therapeutics Key Players in Central & South America
11.3 Central & South America Venous Thromboembolism Therapeutics Market Size by Type
11.4 Central & South America Venous Thromboembolism Therapeutics Market Size by Application

12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Venous Thromboembolism Therapeutics Introduction
12.1.4 Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2014-2019)
12.1.5 Johnson & Johnson Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Venous Thromboembolism Therapeutics Introduction
12.2.4 Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2014-2019)
12.2.5 Sanofi Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Details
12.3.2 Company Description and Business Overview
12.3.3 Venous Thromboembolism Therapeutics Introduction
12.3.4 Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2014-2019)
12.3.5 Boehringer Ingelheim Recent Development
12.4 Daiichi Sankyo
12.4.1 Daiichi Sankyo Company Details
12.4.2 Company Description and Business Overview
12.4.3 Venous Thromboembolism Therapeutics Introduction
12.4.4 Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2014-2019)
12.4.5 Daiichi Sankyo Recent Development
12.5 Bristol-Myers Squibb (BMS)
12.5.1 Bristol-Myers Squibb (BMS) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Venous Thromboembolism Therapeutics Introduction
12.5.4 Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2014-2019)
12.5.5 Bristol-Myers Squibb (BMS) Recent Development
12.6 Bayer HealthCare
12.6.1 Bayer HealthCare Company Details
12.6.2 Company Description and Business Overview
12.6.3 Venous Thromboembolism Therapeutics Introduction
12.6.4 Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2014-2019)
12.6.5 Bayer HealthCare Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Venous Thromboembolism Therapeutics Introduction
12.7.4 Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Leo Pharma
12.8.1 Leo Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Venous Thromboembolism Therapeutics Introduction
12.8.4 Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2014-2019)
12.8.5 Leo Pharma Recent Development
12.9 Portola Pharmaceuticals
12.9.1 Portola Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Venous Thromboembolism Therapeutics Introduction
12.9.4 Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2014-2019)
12.9.5 Portola Pharmaceuticals Recent Development
12.10 ThromboGenics
12.10.1 ThromboGenics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Venous Thromboembolism Therapeutics Introduction
12.10.4 ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2014-2019)
12.10.5 ThromboGenics Recent Development
12.11 Ionis Pharmaceuticals
12.12 GlycoMimetics
12.13 BioInvent International

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details